Clinical Trials Directory

Trials / Unknown

UnknownNCT04582188

The Early Coagulopathy for the Prognosis in Sepsis

An Observational Study on the Prognostic Function of Early Coagulopathy in Sepsis Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

In this cohort study, the parameters (TM, TAT, PIC, tPAIC, et al.) associated with the hemostatic system will be collected in sepsis patients when admitted to the Intensive Critical Unit. Parameters will be evaluated for their prognostic function of 28 days mortality.

Detailed description

The object of this study is to find the early mortality prognostic biomarkers within the hemostatic system in sepsis patients. Blood samples will be collected from sepsis patients at admission. Parameters reflect endothelial injury, such as thrombomodulin (TM), tissue type plasminogen activator inhibitor complex (tPAIC), parameters reflect procoagulation condition, such as thrombin-antithrombin complex (TAT), and parameters reflect hyperfibrinolysis, such as plasmin-plasmin inhibitor complex (PIC) will be tested. Based on the results of these parameters, sepsis patients will be divided into coagulation parameter normal or abnormal groups. Twenty-eight days of mortality will be determined by patient follow-up. Regression analysis will be used to evaluate the relationship between these parameters and the mortality of sepsis patients.

Conditions

Timeline

Start date
2020-11-05
Primary completion
2021-03-31
Completion
2022-12-31
First posted
2020-10-09
Last updated
2020-11-06

Source: ClinicalTrials.gov record NCT04582188. Inclusion in this directory is not an endorsement.